Ashburn, VA, United States of America

Jonathan B Grimm

This inventor holds 19 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Fluorescent Compounds. Top assignees: Howard Hughes Medical Institute, Merck Sharp + Dohme Corp., Merck Canada Inc.. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan B Grimm. Retrieved from https://idiyas.com/inventor/jonathan-b-grimm

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 19 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.7

ph-index = 4

Forward Citations = 64(Granted Patents)


Location History:

  • Newton, MA (US) (2011 - 2013)
  • Ashburn, VA (US) (2016 - 2024)

Company Filing History:


Years Active: 2011-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Deuterated Fluorophores
Red-Shifted Fluorophores
Photoactive Fluorophores
Fluorescent Compounds
Spleen Tyrosine Kinase Inhibitors
Janus Kinase Inhibitors
Histone Deacetylase Inhibitors
Azetidine-Substituted Compounds
Triazolyl Derivatives
Imidazolyl Analogs
Aminopyrimidines
Ion-Activated Photolabile Compounds
19 patents (USPTO):Explore Patents

Title: Innovations of Jonathan B. Grimm in Fluorophore Development

Introduction

Jonathan B. Grimm is an accomplished inventor based in Ashburn, VA, with a remarkable portfolio of 18 patents to his name. His work primarily revolves around the development of advanced compounds and methods that greatly contribute to the field of fluorescence and imaging technologies.

Latest Patents

Among his latest innovations, Grimm has introduced breakthroughs in the realm of red-shifted fluorophores, which offer enhanced capabilities for in vivo labeling. This includes a compound structure that encompasses photoactive fluorophores, along with a photoactive ligand and photoactive complex. These inventions incorporate a photoactivatable derivative of an azetidine-containing Janelia-Fluor dye, providing researchers with powerful tools for biological imaging. Furthermore, his methods facilitate in vivo labeling and photoactivation, expanding the utility of these advanced fluorophores significantly.

Career Highlights

Jonathan B. Grimm has made substantial contributions throughout his career, particularly during his tenure with renowned organizations such as Merck Sharp & Dohme Corporation and the Howard Hughes Medical Institute. These experiences have empowered him to pivot his academic insights into practical, innovative applications that benefit various scientific fields.

Collaborations

Throughout his illustrious career, Grimm has collaborated with several talented individuals, including Luke D. Lavis and Kevin J. Wilson. These partnerships have sparked innovation and allowed for the exchange of ideas that enhance research outcomes in their respective domains.

Conclusion

Jonathan B. Grimm's endeavors in the development of photoactive fluorophores and related technologies showcase his significant impact on scientific research and innovations. His 18 patents and collaborations highlight his commitment to advancing the field, establishing him as a notable figure in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…